Skip to main content

Table 1 Patients characteristics, comorbidities, causes of ICU admission, RRT modalities at initiation of therapy and outcome according to the success or failure of RRT weaning attempt

From: Daily urinary creatinine predicts the weaning of renal replacement therapy in ICU acute kidney injury patients

 

All patients (n = 54)

S+ group (n = 26)

S group (n = 28)

p

Age (years)

63.5 [56–72.8]

61.5 [56–71]

67.5 [56.5–75.5]

0.12

Male [n (%)]

36 (67)

20 (77)

16 (51)

0.09

SAPS II

55 [39–69]

54 [39.5–65.8]

56 [40.5–74.5]

0.36

SOFA

11 [8–13]

11 [8.3–13]

11 [8.5–13]

0.51

Previous eGFR (ml/min/1.73 m2)

70 [45–92]

77 [45–96]

65 [46–89]

0.46

Main comorbidities [n (%)]

    

 Hypertension

28 (52)

12 (46)

16 (57)

0.16

 Diabetes

19 (35)

8 (31)

11 (39)

 

 Cardiac failure

8 (15)

4 (15)

4 (14)

 

 Hemopathy

8 (15)

2 (8)

6 (21)

 

Main reason for ICU admission [n (%)]

    

 Septic shock

28 (52)

11 (42)

17 (61)

0.15

 Cardiogenic shock/cardiac arrest

10 (19)

5 (19)

5 (18)

 

 Post-surgical

6 (13)

3 (12)

3 (11)

 

 Other

10 (13)

5 (19)

5 (18)

 

Initial RRT technique [n (%)]

    

 IHDF

19 (35)

6 (23)

13 (46)

0.07

 CVVHDF

19 (35)

13 (50)

6 (21)

 

 SLEDD-f

16 (30)

7 (27)

9 (32)

 

Length of ICU stay (days)

19 [8.3–42]

13.5 [8.3–32.3]

24.5 [17.5–42]

0.012

Duration of RRT (days)

15 [5–35]

10.5 [5–14.8]

18 [10–35]

0.006

In-hospitality mortality [n (%)]

0 (0)

0 (0)

0 (0)

3-month mortality [n (%)]

4 (7.4)

0 (0)

4 (14)

0.11

eGFR at 3 months (ml/min/1.73 m2)

58 [49–92]

66 [68–92]

55 [49–77]

0.08

  1. Italic values indicate significance of p value (p <0.05)
  2. Results are displayed in median [interquartile range] if quantitative variable; and number and percentage if categorial variable
  3. p: differences between S+ and S groups
  4. SAPS II Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment, eGFR estimated glomerular filtration rate, IHDF intermittent hemodiafiltration, CVVHDF continuous venovenous hemodiafiltration, SLEDD-f sustained low-efficiency daily dialysis-filtration, RRT renal replacement therapy